Logo image of ALHC

ALIGNMENT HEALTHCARE INC (ALHC) Stock Fundamental Analysis

NASDAQ:ALHC - Nasdaq - US01625V1044 - Common Stock - Currency: USD

12.41  -0.74 (-5.63%)

After market: 12.36 -0.05 (-0.4%)

Fundamental Rating

3

Overall ALHC gets a fundamental rating of 3 out of 10. We evaluated ALHC against 103 industry peers in the Health Care Providers & Services industry. ALHC may be in some trouble as it scores bad on both profitability and health. ALHC shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALHC has reported negative net income.
In the past year ALHC had a positive cash flow from operations.
In the past 5 years ALHC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALHC reported negative operating cash flow in multiple years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of ALHC (-10.12%) is worse than 77.67% of its industry peers.
ALHC has a Return On Equity of -83.81%. This is in the lower half of the industry: ALHC underperforms 76.70% of its industry peers.
Industry RankSector Rank
ROA -10.12%
ROE -83.81%
ROIC N/A
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 11.57%, ALHC is doing worse than 73.79% of the companies in the same industry.
In the last couple of years the Gross Margin of ALHC has declined.
ALHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

3

2. Health

2.1 Basic Checks

ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALHC has more shares outstanding
ALHC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALHC is higher compared to a year ago.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.93 indicates that ALHC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.93, ALHC is in the better half of the industry, outperforming 73.79% of the companies in the same industry.
ALHC has a debt to FCF ratio of 16.87. This is a negative value and a sign of low solvency as ALHC would need 16.87 years to pay back of all of its debts.
With a Debt to FCF ratio value of 16.87, ALHC perfoms like the industry average, outperforming 42.72% of the companies in the same industry.
ALHC has a Debt/Equity ratio of 2.98. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.98, ALHC is doing worse than 77.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF 16.87
Altman-Z 3.93
ROIC/WACCN/A
WACC8.94%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.69 indicates that ALHC should not have too much problems paying its short term obligations.
ALHC has a Current ratio (1.69) which is comparable to the rest of the industry.
ALHC has a Quick Ratio of 1.69. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
ALHC has a Quick ratio of 1.69. This is in the better half of the industry: ALHC outperforms 61.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.37%, which is quite impressive.
The Revenue has grown by 49.12% in the past year. This is a very strong growth!
The Revenue has been growing by 28.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)43.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)49.12%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%47.46%

3.2 Future

ALHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.00% yearly.
ALHC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.51% yearly.
EPS Next Y47.39%
EPS Next 2Y36.5%
EPS Next 3Y29.21%
EPS Next 5Y33%
Revenue Next Year41.91%
Revenue Next 2Y33.96%
Revenue Next 3Y30.53%
Revenue Next 5Y25.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2031 2B 4B 6B 8B 10B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

61.16% of the companies in the same industry are cheaper than ALHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 128.71
EV/EBITDA N/A
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as ALHC's earnings are expected to grow with 29.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.5%
EPS Next 3Y29.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (7/18/2025, 8:00:01 PM)

After market: 12.36 -0.05 (-0.4%)

12.41

-0.74 (-5.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners61.66%
Inst Owner Change0%
Ins Owners5.28%
Ins Owner Change19.54%
Market Cap2.46B
Analysts82.22
Price Target18.74 (51.01%)
Short Float %8.74%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.85%
Min EPS beat(2)18.53%
Max EPS beat(2)61.17%
EPS beat(4)4
Avg EPS beat(4)23.63%
Min EPS beat(4)3.21%
Max EPS beat(4)61.17%
EPS beat(8)6
Avg EPS beat(8)13.78%
EPS beat(12)9
Avg EPS beat(12)18.35%
EPS beat(16)11
Avg EPS beat(16)4.29%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)1.59%
Max Revenue beat(2)2.3%
Revenue beat(4)4
Avg Revenue beat(4)2.79%
Min Revenue beat(4)1.59%
Max Revenue beat(4)4.75%
Revenue beat(8)8
Avg Revenue beat(8)2.67%
Revenue beat(12)11
Avg Revenue beat(12)3.12%
Revenue beat(16)15
Avg Revenue beat(16)4.1%
PT rev (1m)0%
PT rev (3m)5.91%
EPS NQ rev (1m)2.04%
EPS NQ rev (3m)4%
EPS NY rev (1m)0.2%
EPS NY rev (3m)14.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF 128.71
P/OCF 42.61
P/B 22.71
P/tB 35.38
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.1
FCFY0.78%
OCF(TTM)0.29
OCFY2.35%
SpS15.17
BVpS0.55
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.12%
ROE -83.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.57%
FCFM 0.64%
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
F-Score6
Asset Turnover3.35
Health
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF 16.87
Debt/EBITDA N/A
Cap/Depr 134.51%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 3.93
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)151.69%
Cap/Depr(5y)136.01%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y47.39%
EPS Next 2Y36.5%
EPS Next 3Y29.21%
EPS Next 5Y33%
Revenue 1Y (TTM)49.12%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%47.46%
Revenue Next Year41.91%
Revenue Next 2Y33.96%
Revenue Next 3Y30.53%
Revenue Next 5Y25.51%
EBIT growth 1Y52.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.54%
EBIT Next 3Y53.1%
EBIT Next 5YN/A
FCF growth 1Y-24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.33%
OCF growth 3YN/A
OCF growth 5Y30.43%